A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE2
Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
- Status
- TERMINATED
- Phase
- PHASE3
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin
- Status
- COMPLETED
- Phase
- PHASE1